NCT07851558

Brief Summary

ERAS (Enhanced Recovery After Surgery) is a set of steps used around surgery to help patients recover faster and better. ERAS guidelines have been adopted in several surgical fields, and evidence-based recommendations have recently been developed for cesarean delivery as well. These guidelines address multiple parts of post-operative care, including prevention of nausea and vomiting, pain control, thromboprophylaxis, early mobilization, urinary catheter use, and discharge counseling. Early mobilization is a key element of ERAS, but there is currently limited high-quality evidence about its specific benefits after cesarean delivery. In theory, mobilizing earlier may reduce thromboembolic events, shorten hospitalization, and speed up return of bowel function. Another important ERAS component is avoiding routine urinary catheter use. Evidence suggests that a no-catheter policy can shorten the time to first mobilization, first eating, and first bowel movement, and can reduce overall hospital stay compared with routine catheter use around cesarean delivery. In a randomized controlled trial of 300 women assigned to immediate versus delayed (12-hour) catheter removal after cesarean delivery, immediate removal reduced bacteriuria and urinary symptoms (dysuria, frequency, urgency), and also shortened time to first mobilization and length of stay. A systematic review also found that inserting a catheter before cesarean delivery increases the risk of urinary tract infection without improving surgical ease. A 2014 Cochrane review concluded that routine catheter use increases time to first urination, increases discomfort, delays mobilization, and prolongs hospital stay. The aim of the present study is to compare early mobilization combined with no urinary catheter in women undergoing planned cesarean delivery versus standard perioperative care, to improve recovery after surgery.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
260

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started Oct 2021

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

October 21, 2021

Completed
3.2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 6, 2025

Completed
8 months until next milestone

Study Completion

Last participant's last visit for all outcomes

September 10, 2025

Completed
8 months until next milestone

First Submitted

Initial submission to the registry

April 26, 2026

Completed
5 months until next milestone

First Posted

Study publicly available on registry

October 1, 2026

Completed
Last Updated

October 1, 2026

Status Verified

October 1, 2021

Enrollment Period

3.2 years

First QC Date

April 26, 2026

Last Update Submit

September 28, 2026

Conditions

Outcome Measures

Primary Outcomes (1)

  • Enhanced recovery

    composite outcome scoring positive on 2/3 components: Recovery questionnaire score above 118, step count above 454 and non opioid use

    24 hours

Secondary Outcomes (11)

  • Inability to Ambulate on First Postoperative Attempt

    At first postoperative ambulation attempt- between 4-8 hours postoperative

  • Pre and post ambulation Pain Score on the Visual Analog Scale

    Immediately before and after first postoperative ambulation

  • Postoperative Pain Score at 2-12 Hours

    2-12 hours after surgery

  • Maternal Satisfaction Score at 24 Hours and 1 week after surgery and in comparison to previous Cesarean Section

    24 hours and 1 week after surgery

  • Post-surgical Complication Within 7 Days of surgery

    From surgery through postoperative day 7

  • +6 more secondary outcomes

Study Arms (2)

Control

NO INTERVENTION

Urine catheter at surgery and regular ambulation after 8 hours

enhanced ERAS

EXPERIMENTAL

Omission of urinary catheter and early ambulation after 4 hours

Procedure: Enhanced Recovery protocol

Interventions

Omission of urinary catheter and early ambulation

enhanced ERAS

Eligibility Criteria

Sexfemale
Healthy VolunteersYes
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)

You may qualify if:

  • elective surgery
  • Singleton

You may not qualify if:

  • placenta accreta
  • Limited mobility
  • Allergy to nsaids/paracetamol/optalgin

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Bnei Zion

Haifa, Israel

Location

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
SUPPORTIVE CARE
Intervention Model
PARALLEL
Sponsor Type
OTHER GOV
Responsible Party
SPONSOR

Study Record Dates

First Submitted

April 26, 2026

First Posted

October 1, 2026

Study Start

October 21, 2021

Primary Completion

January 6, 2025

Study Completion

September 10, 2025

Last Updated

October 1, 2026

Record last verified: 2021-10

Data Sharing

IPD Sharing
Will share

De-identified individual participant data (including data dictionary) will be shared. Requests may be submitted to liannapinsky@gmail.co. Access will be provided to qualified researchers for analyses under a data use agreement.

Shared Documents
STUDY PROTOCOL, CSR
Time Frame
May 2026
Access Criteria
ualified researchers may request access to de-identified individual participant data and supporting information by contacting the study team at liannapinsky@gmail.com. Requests will be reviewed by the investigators, and access will be granted for scientifically valid research purposes after approval of the request and completion of a data access/use agreement.

Locations